Background: Warfarin is an effective agent in the prevention of stroke in patients with atrial fibrillation (AF), yet it requires close monitoring. Rural patients often have decreased access to health care, and may be good candidates for new oral anticoagulants that require less monitoring. However, it is unknown whether there is a difference in warfarin treatment and outcomes between urban and rural settings. methods: We compared warfarin utilization patterns, and stroke and bleeding outcomes in rural and urban settings in a population-based cohort study of patients aged 65 years or older admitted to hospital with a diagnosis of AF in Quebec, Canada, 1999Canada, -2007. We used linkage between hospital discharge databases, physicians and prescription drug claims. Patients' postal codes were used to differentiate between rural and urban locations. Rural locations were areas where there are no letter carriers (i.e. residents go to a post office or postal box to pick-up their mail).
